subject: Pharmaceutical Anti-counterfeiting Strategies And Commercial Analysis [print this page] Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020
Report Details
how will the industry and regulators stem the tide of counterfeits?
The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as our new report explains and quantifies. Counterfeit drugs cost the pharmaceutical industry billions of dollars annually in lost revenues, with risk to patients and brands. Drug counterfeiting is increasing worldwide, with greater sophistication by counterfeiters and increased online drug purchasing. The rising prevalence of counterfeiting yields significant commercial opportunities for companies offering anti-counterfeiting solutions, as well as for their clients. Companies worldwide are investing in technologies to fight this threat to pharma stakeholders. ( http://www.bharatbook.com/detail.asp?id=144426&rt=Pharmaceutical-Anti-counterfeiting-Strategies-and-Commercial-Analysis-2010-2020.html )
As our new report Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020 shows, the pharmaceutical anti-counterfeiting sector offers substantial benefits to the pharmaceutical industry and to suppliers of technology. All segments of the pharmaceutical anti-counterfeiting market have been growing, but which will grow fastest in years to come? What are the main technological and commercial trends to watch? What factors will drive growth of the market from 2010-2020? What will be the main restraints facing the market? How will the pharmaceutical anti-counterfeiting market appear in 2020? This report covers those and other questions, providing the information that you need.
From 2010 onwards, success in the pharmaceutical anti-counterfeiting sector will be characterized by the launch of new solutions with superior performance. Our report describes how emerging technologies will set higher barriers for drug counterfeiters, impeding the flow of counterfeits into distribution channels. Our new report also discusses steps the authorities are taking, in conjunction with industry.
Detailed analysis of the pharmaceutical anti-counterfeiting sector
Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020 examines that sector through a comprehensive review of information sources. We use primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D developments and analyses of commercial drivers and restraints, including SWOT analysis. There are comprehensive tables and figures, as well as an interview with experts from the sector. The result is a detailed market- and industry-centered study with analyses and opinion to benefit your work.
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=144426&rt=Pharmaceutical-Anti-counterfeiting-Strategies-and-Commercial-Analysis-2010-2020.html
